Twist Bioscience Corporation (TWST) vs 10x Genomics, Inc. (TXG)
A side-by-side comparison of Twist Bioscience Corporation and 10x Genomics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
TWST
Twist Bioscience Corporation
$166.97HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
TXG
10x Genomics, Inc.
$80.66HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — TWST vs TXG
growth of $100 · dividends reinvested · last 7yTWST +609.3% (+32.3%/yr)TXG +85.3% (+9.2%/yr)TWST compounded faster over this window
TWST TXG
TWST vs TXG: by the numbers
- •TWST is the larger company ($10.40B vs $10.24B market cap).
- •Both run net losses; TXG's is the smaller (-12.18% vs -31.66% net margin).
- •TWST grew revenue faster over the past five years (27.77% vs 8.74% CAGR).
Metrics side by side
Valuation
| Metric | TWST | TXG |
|---|---|---|
| P/S ratio | 24.08 | 16.60 |
| P/B ratio | 23.33 | 12.40 |
| FCF yield | N/A | 1.19% |
Profitability
| Metric | TWST | TXG |
|---|---|---|
| Gross margin | 51.97% | 70.03% |
| Operating margin | -31.91% | -14.33% |
| Net margin | -31.66% | -12.18% |
| ROE | -30.67% | -9.10% |
| ROIC | -24.57% | -9.57% |
Growth (annualized)
| Metric | TWST | TXG |
|---|---|---|
| Revenue CAGR (5Y) | 27.77% | 8.74% |
| Total return CAGR (5Y) | 15.59% | -7.24% |
Frequently asked
- Which has grown faster, TWST or TXG?
- Over the past five years, TWST grew revenue faster — TWST at a 27.77% CAGR versus TXG at 8.74%.
- How have TWST and TXG total returns compared?
- Over the past 5 years, TWST delivered 15.59% and TXG delivered -7.24% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Twist Bioscience ROE10x Genomics ROETwist Bioscience operating margin10x Genomics operating marginTwist Bioscience revenue growth10x Genomics revenue growthTwist Bioscience free cash flow10x Genomics free cash flow
Twist Bioscience & 10x Genomics appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.